Gary Owens Succeeds John Sullivan as Chief Executive Officer on September 1, 2017 John Sullivan to Continue as Chairman of Mesa’s Board Lakewood, Colorado, September 1, 2017 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported that Gary Owens has been approved unanimously by Mesa’s Board of Directors (the…
Lakewood, Colorado, July 5, 2017 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2017, to shareholders of record at the close of business…
Lakewood, Colorado, July 31, 2017 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record revenues for the first quarter ended June 30, 2017. Revenues for the first quarter increased seven percent to $22,673,000 as compared to $21,114,000 for the same quarter last year. Operating income for the first quarter…
Lakewood, Colorado, June 7, 2017 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record net income and adjusted net income for the year ended March 31, 2017. Highlights for the year ended March 31, 2017 as compared to last year: Revenues increased 11 percent Non-GAAP adjusted net income1 increased…
Lakewood, Colorado, April 5, 2017 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 15, 2017, to shareholders of record at the close of business…
Lakewood, Colorado, February 2, 2017 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record revenues and adjusted net income for the third quarter ended December 31, 2016. Highlights for the current quarter ended December 31, 2016 as compared to the same period last year: Revenues increased 20 percent Adjusted…
Lakewood, Colorado, January 3, 2017 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 15, 2017, to shareholders of record at the close of business…
Partner models consist of a healthcare institution operating a specialty pharmacy in partnership or in contract with another entity to offer the full range of services required for an accredited specialty pharmacy. Accreditation standards are a valuable resource to healthcare pharmacy leaders to ensure that all internal and partner specific regulatory components are in place.…
It is critical for any healthcare institution to understand the details of applicable laws and regulations to structure its approach to specialty pharmacy practices. The first step is to do a gap analysis of state and federal regulations pertaining to specialty pharmacy services. Risk Evaluation and Mitigation Strategies (REMS) requirements for specific products must also…
Specialty drugs are distinguished by two main characteristics: cost and complexity. Specialty drugs are expensive because of their delicate nature such as limited shelf life, need for climate-controlled shipping and meticulous storage. Specialty drugs are complex because they require special handling and services, inventory management and intense administration. They also need a high level of…